Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Rolley E. Johnson"'
Autor:
Colleen Rock, Rolley E. Johnson, Diana G. Wilkins, Sarah K. Himes, Marilyn A. Huestis, Hendrée E. Jones, Robert S. Goodwin
Publikováno v:
Therapeutic Drug Monitoring. 34:337-344
Methadone is the recommended pharmacotherapy for opioid-dependent pregnant women. The primary aims of this study were to determine whether a dose-concentration relationship exists between cumulative maternal methadone dose, methadone and metabolite c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3d1cc1dfefec59b9bf9ca87b6b0016
https://doi.org/10.1097/ftd.0b013e3182512b26
https://doi.org/10.1097/ftd.0b013e3182512b26
Publikováno v:
Therapeutic Drug Monitoring. 33:619-626
Background: Buprenorphine is currently under investigation as a pharmacotherapy to treat pregnant women for opioid dependence. This research evaluates buprenorphine (BUP), norbuprenophine (NBUP), buprenorphine–glucuronide (BUP-Gluc), and norbupreno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb854fb93315d7901681572628e252f
https://doi.org/10.1097/ftd.0b013e318228bb2a
https://doi.org/10.1097/ftd.0b013e318228bb2a
Autor:
Teresa R. Gray, Diaa M. Shakleya, Ana de Castro, Hendrée E. Jones, Rolley E. Johnson, Marilyn A. Huestis
Publikováno v:
Therapeutic Drug Monitoring. 33:443-452
The purpose was to explore methadone and 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) umbilical cord disposition, correlate with maternal methadone dose and neonatal outcomes, and evaluate the window of drug detection in umbilical cord of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9be9a3fcbb4ce9de6a72350c41c1a76
https://doi.org/10.1097/ftd.0b013e31822724f0
https://doi.org/10.1097/ftd.0b013e31822724f0
Publikováno v:
Journal of Substance Abuse Treatment. 40:255-264
Background Cocaine abuse and dependence continue to be widespread. Currently, there are no pharmacotherapies shown to be effective in the treatment of cocaine dependence. Methods A 33-week outpatient clinical trial of fluoxetine (60 mg/day, po) for c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c4127cdb8fcb62479e87baf2c8b2fa
https://doi.org/10.1016/j.jsat.2010.11.010
https://doi.org/10.1016/j.jsat.2010.11.010
Publikováno v:
Substance Use & Misuse. 45:2244-2257
This study examined the neurobehavioral functioning of neonates prenatally exposed to methadone (n = 11) or buprenorphine (n = 10), who underwent the Neonatal Intensive Care Unit Network Neurobehavioral Scale (NNNS) examinations on days 3, 5, 7, 10,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6201f4e1ef1606d13643a7c3f6cd3e1
https://doi.org/10.3109/10826084.2010.484474
https://doi.org/10.3109/10826084.2010.484474
Autor:
Marilyn A. Huestis, Diaa M. Shakleya, Robin E. Choo, Hendrée E. Jones, Rolley E. Johnson, Marta Concheiro
Publikováno v:
Therapeutic Drug Monitoring. 32:206-215
Buprenorphine is approved as pharmacotherapy for opioid dependence in nonpregnant patients in multiple countries and is currently under investigation for pregnant women in the United States and Europe. This research evaluates the disposition of bupre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5af1c1988d1b2ebe5cd189f843a836bf
https://doi.org/10.1097/ftd.0b013e3181d0bd68
https://doi.org/10.1097/ftd.0b013e3181d0bd68
Publikováno v:
Journal of Chromatography B. 878:13-20
An LCMSMS method was developed and fully validated for the simultaneous quantification of buprenorphine (BUP), norbuprenorphine (NBUP), buprenorphine-glucuronide (BUP-Gluc), and norbuprenorphine-glucuronide (NBUP-Gluc) in 0.5mL plasma, fulfilling con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97fa772c1b9a7619d2e6b6f7e41ff579
https://doi.org/10.1016/j.jchromb.2009.11.005
https://doi.org/10.1016/j.jchromb.2009.11.005
Autor:
J. David Haddox, Rolley E. Johnson, Sajan Varughese, Anders Lindholm, Cynthia G. McCormick, Janne Wissel, Deborah Waxman, Lawrence P. Carter, Susan Rosen, Jack E. Henningfield, Vickie Seeger
Publikováno v:
Drug and Alcohol Dependence. 105:S42-S55
The development and implementation of programs in the U.S. to minimize risks and assess unintended consequences of new medications has been increasingly required by the Food and Drug Administration (FDA) since the mid 1990s. This paper provides four
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0afdac6538904429441e9dbb86499950
https://doi.org/10.1016/j.drugalcdep.2009.08.003
https://doi.org/10.1016/j.drugalcdep.2009.08.003
Autor:
Marilyn A. Huestis, Hendrée E. Jones, Sherri L. Kacinko, Rolley E. Johnson, Marta Concheiro-Guisan, Robin E. Choo
Publikováno v:
Clinical Chemistry. 55:1177-1187
Background: Buprenorphine (BUP) is under investigation as a medication therapy for opioid-dependent pregnant women. We investigated BUP and metabolite disposition in urine from women maintained on BUP during the second and third trimesters of pregnan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7cb9587b3e52e7ce9bf40e2f00584b
https://doi.org/10.1373/clinchem.2008.113712
https://doi.org/10.1373/clinchem.2008.113712
Autor:
Kevin E. O'Grady, Donald R. Jasinski, Lorraine Milio, Michelle Tuten, Rolley E. Johnson, Hendrée E. Jones
Publikováno v:
Journal of Addiction Medicine. 2:103-107
Scant scientific attention has been given to examining the need for agonist medication dose changes in the postpartum period. Study objectives were: 1) to determine the need for medication dose adjustments in participants stabilized on buprenorphine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d34e638af4d79d923e24e8c2a15dfd0e
https://doi.org/10.1097/adm.0b013e31815ca2c6
https://doi.org/10.1097/adm.0b013e31815ca2c6